Shelton Capital Management Bio Techne Corp Transaction History

Shelton Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $957,805 - $1.16 Million	-2,153 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $16,542 - $21,565	-67 Reduced 3.02%	2,153 $684,000
Q2 2020 Aug 12, 2020	SELL	$185.43 - $279.56 $21,324 - $32,149	-115 Reduced 4.93%	2,220 $586,000
Q1 2020 May 13, 2020	SELL	$161.17 - $221.51 $18,534 - $25,473	-115 Reduced 4.69%	2,335 $443,000
Q4 2019 Feb 11, 2020	SELL	$189.68 - $222.09 $21,244 - $24,874	-112 Reduced 4.37%	2,450 $538,000
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $384,233 - $438,615	2,036 Added 387.07%	2,562 $534,000
Q1 2019 May 10, 2019	SELL	$136.09 - $200.44 $288,782 - $425,333	-2,122 Reduced 80.14%	526 $2.65 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $22,742 - $26,129	-173 Reduced 6.13%	2,648 $400,000
Q3 2017 Nov 28, 2017	BUY	$113.59 - $123.78 $320,437 - $349,183	2,821 New	2,821 $341,000
Q3 2017 Nov 14, 2017	SELL	$113.59 - $123.78 $320,437 - $349,183	-2,821 Closed	0 $0
Q1 2017 Nov 28, 2017	SELL	N/A	-808 Reduced 22.27%	2,821 $287,000
Q3 2016 Dec 04, 2017	BUY	N/A	3,629	3,629 $373,000

619

156M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.4B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.